Fluid and Electrolyte Balance
Fluid and electrolyte homeostasis is critical for cellular function. Disturbances in sodium, potassium, calcium, and magnesium are common in clinical practice.
Key Facts
Total body water is approximately 60% of body weight in men (50% in women); two-thirds intracellular, one-third extracellular Hyponatraemia (<135 mmol/L) is the most common electrolyte disturbance in hospitalised patients, affecting up to 30% Severe hyperkalaemia (>6.5 mmol/L) is a medical emergency — ECG changes include tall tented T waves, broad QRS, sine wave NICE CG174 recommends Hartmann's solution or 0.9% saline for IV fluid resuscitation in adults Corrected calcium = measured Ca²⁺ + 0.02 × (40 − albumin in g/L) Hyponatraemia correction must not exceed 10-12 mmol/L in 24 hours to avoid osmotic demyelination syndrome Daily maintenance fluid requirements: 25-30 mL/kg/day water, 1 mmol/kg/day Na⁺/K⁺/Cl⁻, 50-100g/day glucose ADH (vasopressin) is the key hormone regulating water reabsorption; SIADH is the most common cause of euvolaemic hyponatraemia
Overview
Key Facts
Body fluid is distributed between intracellular (ICF, ~28L) and extracellular (ECF, ~14L) compartments. The ECF is further divided into interstitial fluid (~11L) and plasma (~3L). Osmolarity is the key determinant of water distribution between compartments.
Epidemiology
Electrolyte disturbances are among the most common abnormalities encountered in hospital medicine. Hyponatraemia affects 15-30% of hospitalised patients. Hyperkalaemia occurs in approximately 8% of hospitalised patients and is the most common electrolyte cause of cardiac arrest. Hypokalaemia affects approximately 20% of hospitalised patients.
Aetiology
Electrolyte disturbances arise from:
- Altered intake: IV fluids, diet, TPN
- Altered losses: GI (vomiting, diarrhoea, fistulae), renal (diuretics, RTA), insensible (fever, burns)
- Redistribution: Insulin shifts K⁺ intracellularly; metabolic alkalosis drives K⁺ into cells
- Hormonal: Aldosterone (Na⁺ retention, K⁺ excretion), ADH (water retention), PTH (Ca²⁺ regulation)
Pathophysiology
- Sodium determines ECF osmolality and volume — hyponatraemia reflects relative water excess
- Potassium determines resting membrane potential — disturbances cause cardiac arrhythmias
- Calcium is essential for muscle contraction, nerve conduction, and coagulation — 40% protein-bound
- Magnesium is a cofactor for >300 enzymatic reactions — deficiency causes refractory hypokalaemia and hypocalcaemia
- Starling forces govern fluid movement across capillaries: hydrostatic vs oncotic pressure gradients
Clinical Presentation
Hyponatraemia
- Mild (130-134): Often asymptomatic
- Moderate (125-129): Nausea, headache, confusion
- Severe (<125): Seizures, coma, respiratory arrest
Hyperkalaemia
- Muscle weakness, paraesthesia, palpitations
- ECG changes: tall tented T waves → loss of P waves → broad QRS → sine wave → cardiac arrest
Hypokalaemia
- Muscle weakness, cramps, constipation, ileus
- ECG: Flattened T waves, ST depression, prominent U waves, prolonged QT
Hypercalcaemia
- "Bones, stones, groans, and psychic moans": Bone pain, renal stones, abdominal pain/constipation, confusion/depression
Hypocalcaemia
- Perioral paraesthesia, carpopedal spasm, Chvostek's sign, Trousseau's sign, prolonged QT
Red Flags
- K⁺ >6.5 mmol/L or ECG changes — immediate treatment
- Na⁺ <120 mmol/L with seizures — 100mL hypertonic (3%) saline bolus
- Corrected Ca²⁺ >3.5 mmol/L — urgent hydration and bisphosphonate
Differential Diagnosis
| Diagnosis | Key Features | Investigation |
|---|---|---|
| SIADH | Euvolaemic hyponatraemia, concentrated urine, low serum osmolality | Paired serum and urine osmolality/Na⁺ |
| Addison's disease | Hyponatraemia, hyperkalaemia, postural hypotension | Short Synacthen test, cortisol |
| Primary hyperaldosteronism | Hypokalaemia, hypertension, metabolic alkalosis | Aldosterone:renin ratio |
| Primary hyperparathyroidism | Hypercalcaemia, raised PTH, renal stones | Ca²⁺, PTH, phosphate |
| Malignancy-related hypercalcaemia | PTHrP-mediated or bony metastases | PTHrP, myeloma screen, CT |
| Acute kidney injury | Hyperkalaemia, raised creatinine, oliguria | U&Es, renal USS |
Diagnosis / Investigation
Bedside
- ECG: Essential in hyper/hypokalaemia and hypocalcaemia
- Fluid balance chart: Input/output monitoring
- Weight: Daily — 1kg change ≈ 1L fluid
- Urine dipstick: Specific gravity, osmolality estimate
Bloods
- U&Es: Na⁺, K⁺, urea, creatinine, eGFR
- Bone profile: Corrected Ca²⁺, phosphate, ALP
- Magnesium: Always check in refractory hypokalaemia
- Serum osmolality: Normal 280-295 mOsm/kg
- Thyroid function, cortisol: Exclude hypothyroidism and adrenal insufficiency in hyponatraemia
Imaging
- CXR: Fluid overload assessment
- Renal USS: Obstructive uropathy, renal size
Special Tests
- Paired urine and serum osmolality: Diagnose SIADH
- Urine Na⁺: <20 mmol/L suggests pre-renal/hypovolaemic; >40 mmol/L suggests renal loss or SIADH
- Short Synacthen test: Exclude adrenal insufficiency
- PTH level: Differentiate causes of hypercalcaemia
Management
Non-pharmacological
- Fluid restriction (750-1000 mL/day): First-line for SIADH
- IV fluid therapy per NICE CG174: Assess volume status before prescribing
- Dietary potassium restriction: In CKD with hyperkalaemia
Pharmacological
Hyperkalaemia emergency treatment:
- Calcium gluconate 10% 10mL IV over 2 min (cardioprotection) — does NOT lower K⁺
- Insulin 10 units + glucose 50mL 50% IV — shifts K⁺ intracellularly (onset 15-30 min)
- Salbutamol 10-20mg nebulised — additional K⁺ shifting
- Calcium resonium 15g TDS PO or sodium zirconium cyclosilicate 10g TDS — K⁺ binders
Hyponatraemia:
- Acute symptomatic: Hypertonic saline (3%) 100-150mL over 20 min
- Chronic: Fluid restriction, demeclocycline 300mg BD, tolvaptan 15mg OD (specialist only)
Hypocalcaemia:
- Acute symptomatic: 10mL calcium gluconate 10% IV over 10 min, then infusion
- Chronic: Alfacalcidol 0.25-1mcg OD + calcium carbonate 1.25g BD
Referral Criteria
- Refractory electrolyte disturbances — endocrinology/nephrology
- Sodium <120 mmol/L or >155 mmol/L — critical care
- Suspected endocrine cause — endocrinology
Prognosis
- Severe hyponatraemia (<120 mmol/L): mortality up to 50% if untreated; osmotic demyelination syndrome if corrected too rapidly (>10-12 mmol/L/day)
- Hyperkalaemia-related cardiac arrest: poor outcomes; preventable with early recognition
- SIADH: Prognosis depends on underlying cause; drug-induced SIADH resolves on drug withdrawal
- Hypercalcaemic crisis (Ca²⁺ >3.5): mortality 50% without treatment
- Chronic electrolyte disorders: increase falls risk, hospital stay, and mortality in elderly patients
Other Relevant Information
IV Fluid Composition
| Fluid | Na⁺ | K⁺ | Cl⁻ | Lactate | Osmolality |
|---|---|---|---|---|---|
| 0.9% NaCl | 154 | 0 | 154 | 0 | 308 |
| Hartmann's | 131 | 5 | 111 | 29 | 278 |
| 5% Dextrose | 0 | 0 | 0 | 0 | 278 |
| Dextrose-saline | 30 | 0 | 30 | 0 | 286 |
Hyponatraemia Classification
| Volume Status | Urine Na⁺ <20 | Urine Na⁺ >40 |
|---|---|---|
| Hypovolaemic | GI losses, burns | Diuretics, Addison's |
| Euvolaemic | Polydipsia | SIADH, hypothyroidism |
| Hypervolaemic | CCF, cirrhosis, nephrotic | AKI, CKD |